The College’s Board met on June 25, 2025. At their June meeting, the College’s Board started their new governance year, approved a new pathway to College registration for Indigenous midwives, approved the annual financial statements, sent proposed changes to the Designated Drugs and Substances Regulation out for public consultation, annual committee reports, and more. You can read the full Board package on our website here.
New Governance Year
The College launched its new governance year with a constituted Board, consisting of eight Professional Directors and five Public Directors. The Board composition is as follows:
Professional Directors
- Claire Ramlogan-Salanga, RM, Chair
- Edan Thomas, RM, Vice-Chair, Professional
- Lynne-Marie Culliton, RM
- Abir Hoblos, RM
- Isabelle Milot, RM
- Jyothy Nair, RM
- Maryam Rahimi-Chatri, RM
- Alexia Singh, RM
Public Directors
- Donald Strickland, Vice-Chair, Public
- Marianna Kaminska
- Judith Murray
- Christopher Panos
- Tina Walia-Rao
Updated Committee compositions have been posted to our website here.
Executive Committee Elections
The Board held elections for its Executive Committee and acclaimed the following Board Directors:
- Chair: Claire Ramlogan-Salanga, RM
- Vice-Chair, Public: Don Strickland
- Vice-Chair, Professional: Edan Thomas, RM
- Member-at-Large, Public: Tina Walia-Rao
- Member-at-Large, Professional: Isabelle Milot, RM
Thank you and congratulations to everyone who put their names forward.
Annual Committee Reports
The College’s statutory committees submitted their annual reports to the Board in the June meeting. The annual reports share committee composition; information on the number of times each committee met, the number of panels (as relevant), and the number of training days; an overview of the committee’s work from the year; and quantitative data of panel and program caseload, themes, outcomes and timelines, where applicable. An annual report of registration data was also shared, with data on incoming midwives and attrition.
Board and Committee Training 2025-2026 Governance Year
Each year, the College delivers training to Board and Committee members to support informed, fair, and inclusive decision-making. For the 2025–26 governance year, sessions will focus on foundational training as well as emerging knowledge and skill areas identified through the Board’s annual evaluation and continuous improvement priorities. This year, Board and Committee training will focus on governance modernization, procedural fairness, human rights and reconciliation, Indigenous governance and knowledge systems, and leadership training that focuses on Chair roles and responsibilities.
Committee-specific training will continue throughout the year, grounded in the College’s legislation and adapted to reflect the ongoing work and needs of each regulatory program.
Audited Financial Statements
The Board approved the College’s 2024-25 audited financial statements, as presented by Hilborn LLP. You can review the financial statements in the Board Meeting Package.
2024-25 Registrar Review
As part of our commitment to accountability and transparency and in accordance with the College’s Governance Policies, the Board’s Executive Committee reviews the Registrar’s performance annually. This year’s review was conducted with the support and guidance of consultants The Pod Group and presented to the Board at the June 2025 meeting.
Approval of New Pathway to College Registration for Indigenous Midwives
At the June 25, 2025, meeting, the Board created a new pathway for Indigenous midwives who wish to become registered with the College of Midwives of Ontario.
The Indigenous Advanced Education and Skills Council (IAESC) has been approved as the designated body with the authority to identify Indigenous midwifery education baccalaureate degrees as equivalent qualifications to Ontario baccalaureate degrees in Midwifery for entry to practice under the Registration Regulation.
Consultation: Designated Drugs and Substances Regulation
The College of Midwives of Ontario is consulting the public and midwives on a proposed change to the Designated Drugs and Substances Regulation under the Midwifery Act, 1991, to add the Respiratory Syncytial Virus (RSV) monoclonal antibody to the list of drugs and substances that midwives can prescribe and administer. RSV is a serious, potentially life-threatening illness which leads to the hospitalization of newborns in Ontario every year, and monoclonal antibody immunization is currently recommended by the National Advisory Committee on Immunization (NACI) to prevent this disease.
We welcome all feedback on this proposal from members of the public, clients, midwives, and system partners. Please share your comments on our website.
Strategic Planning
The 2021-2026 Strategic Plan is concluding this fiscal year, and the College is working to create a new plan that will lead us forward. On June 24, 2025, the Board, non-Board Committee Members, and staff met for a facilitated conversation on specific areas of focus for the coming years. The conversation was lively and fruitful, and staff plan to bring a draft strategic plan to the Board for approval at the November 2025 Board Meeting.
